Novo to buy 20% stake in UK’s ConvaTec
Novo A/S, the holding company for the Novo Group and fully owned subsidiary of the Novo Nordisk Foundation, has announced plans to acquire a 19.95 percent stake in UK medical products and technologies group ConvaTec for around for £1.01 billion.
Read More
